HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters

Journal of Affective Disorders

Volumn 111, Issue 1, 2008, Pages 119-124

  Jokinen, Jussi ^a   Samuelsson, Mats ^a   Nordström, Anna Lena ^a   Nordström, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CSF 5 HIAA; CSF HVA; Depression severity; Suicide intent; T3; TRH test

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; LIOTHYRONINE; PROTIRELIN; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; BECK SUICIDE INTENT SCALE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIOTHYRONINE BLOOD LEVEL; LUMBAR PUNCTURE; MALE; METABOLITE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATIENT; PRIORITY JOURNAL; PROTIRELIN TEST; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT;

ADULT; CONTROL GROUPS; DEPRESSIVE DISORDER; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; SPINAL PUNCTURE; STIMULATION, CHEMICAL; SUICIDE; SUICIDE, ATTEMPTED; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; TRIIODOTHYRONINE; VIOLENCE;

EID: 52149120498     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.02.001     Document Type: Article

References (30)

1. Altshuler L.L., Bauer M., Frye M.A., Gitlin M.J., Mintz J., Szuba M.P., Leight K.L., and Whybrow P.C. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am. J. Psychiatry 158 (2001) 1617-1622
2. Banki C.M., Arato M., Papp Z., and Kurcz M. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine test. J. Affect. Disord 6 (1984) 341-350
3. Beck A.T., Schuyler D., and Herman I. Development of suicidal intent scales, in the prediction of suicide. In: Beck A.T., Resnik H.L., and Lettieri D.J. (Eds). The prediction of suicide (1974), Charles Press, Bowie, MD 45-56
4. Beck A.T., Beck R., and Kovacs M. Classification of suicidal behaviors: I. Quantifying intent and medical lethality. Am. J. Psychiatry 132 3 (1975) 285-287
5. Cleare A.J., McGregor A., and O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clin. Endocrinology (Oxf) 43 (1995) 713-719
6. Corrigan M.H., Gillette G.M., Quade D., and Garbutt J.C. Panic, suicide, and agitation: Independent correlates of the TSH response to TRH in depression. Biol. Psychiatry 31 (1992) 984-992
7. Duval F., Mokrani M.C., Bailey P., Correa H., Diep T.S., Crocq M.A., and Macher J.P. Thyroid axis activity and serotonin function in major depressive episode. Psychoneuroendocrinology 24 (1999) 695-712
8. Gold P.W., Goodwin F.K., Wehr T., and Rebar R. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites. Am. J. Psychiatry 134 (1977) 1028-1031
9. Joffe R.T., and Sokolov S.T. Thyroid hormone treatment of primary unipolar depression: a review. Int. J. Neuropsychopharmacol. 3 (2000) 143-147
10. Kastin A.J., Ehrensing R.H., Schalch D.S., and Anderson M.S. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet 2 7780 (1972) 740-742
11. Korner A., Kirkegaard C., and Larsen J.K. The thyrotropin response to thyrotropin-releasing hormone as a biological marker of suicidal risk in depressive patients. Acta Psychiatr. Scand. 76 (1987) 355-358
12. Larsen J.K., Faber J., Christensen E.M., Bendsen B.B., Solstad K., Gjerris A., and Siersbaek-Nielsen K. Relationship between mood and TSH response to TRH stimulation in bipolar affective disorder. Psychoneuroendocrinology 29 7 (2004) 917-924
13. Linkowski P., Van Wettere J.P., Kerkhofs M., Brauman H., and Mendlewicz J. Thyrotrophin response to thyreostimulin in affectively ill women relationship to suicidal behaviour. Br. J. Psychiatry 143 (1983) 401-405
14. Linkowski P., Van Wettere J.P., Kerkhofs M., Gregoire F., Brauman H., and Mendlewicz J. Violent suicidal behavior and the thyrotropin-releasing hormone-thyroid-stimulating hormone test: a clinical outcome study. Neuropsychobiology 12 (1984) 19-22
15. Loosen P.T., and Prange Jr. A.J. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am. J. Psychiatry 139 (1982) 405-416
16. Loosen P.T. The TRH-induced TSH response in psychiatric patients: a possible neuroendocrine marker. Psychoneuroendocrinology 10 (1985) 237-260
17. Maes M., Vandewoude M., Schotte C., Martin M., Blockx P., Scharpe S., and Cosyns P. Hypothalamic-pituitary-adrenal and -thyroid axis dysfunctions and decrements in the availability of L-tryptophan as biological markers of suicidal ideation in major depressed females. Acta Psychiatr. Scand. 80 (1989) 13-17
18. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 4 (2003) 819-828
19. Mann J.J., and Currier D. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch. Suicide Res. 11 1 (2007) 3-16
20. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
21. Peabody C.A., Whiteford H.A., Warner M.D., Faull K.F., Barchas J.D., and Berger P.A. TRH stimulation test and depression. Psychiatry Res. 22 1 (1987) 21-28
22. Posternak M., Novak S., Stern R., Hennessey J., Joffe R., Prange A., and Zimmerman M. A pilot effectiveness study: placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response. Int. J. Neuropsychopharmacol. 13 (2007) 1-11
23. Prange Jr. A.J., Lara P.P., Wilson I.C., Alltop L.B., and Breese G.R. Effects of thyrotropin-releasing hormone in depression. Lancet 2 7785 (1972) 999-1002
24. Roy A., Karoum F., Linnoila M., and Pickard D. Thyrotropin releasing hormone test in unipolar depressed patients and controls: relationship to clinical and biological variables. Acta Psychiatr. Scand. 77 (1988) 151-159
25. Samuelsson M., Jokinen J., Nordstrom A.L., and Nordstrom P. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatr. Scand. 113 (2006) 44-47
26. Sher L., Carballo J.J., Grunebaum M.F., Burke A.K., Zalsman G., Huang Y.Y., Mann J.J., and Oquendo M.A. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord. 8 (2006) 543-550
27. Strawn J.R., Ekhator N.N., D'Souza B.B., and Geracioti Jr. T.D. Pituitary-thyroid state correlates with central dopaminergic and serotonergic activity in healthy humans. Neuropsychobiology 49 (2004) 84-87
28. Targum S.D. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse. Biol. Psychiatry 19 3 (1984) 305-318
29. Traskman L., Asberg M., Bertilsson L., and Sjostrand L. Monoamine metabolites in CSF and suicidal behaviour. Arch. Gen. Psychiatry 38 (1981) 631-636
30. Yhede R., Blennow K., Forsman A., and Soderstrom H. The activity in the CNS catecholaminergic systems covaries with thyroid hormone metabolism in humans. J. Neural. Transm. 110 12 (2003) 1369-1373